GlobalResearch and clinical trials
Pregnancy in Bartter and Gitelman syndromes: published cases reviewed
Doctors from Australia reviewed publications on pregnancy in these two kidney diseases.
Peer-reviewed publicationBartter
Kidney diseases
Bartter syndrome
A group of inherited diseases in which the kidneys cannot hold on to salt. The body loses too much salt, water and potassium. Passing a lot of urine and poor growth may be seen.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Kidney diseases” group.
Understanding the disease
This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.
What happens in this disease?
The channels in the kidney that take back salt do not work well. Salt is lost in the urine; potassium and calcium are lost along with it. One type begins before birth and is more severe. The classic type begins in early childhood and is milder.
Which symptoms can occur?
Symptoms vary by type.
- Too much amniotic fluid during pregnancy and a risk of early birth
- Not gaining enough weight in infancy
- Passing a lot of urine, dehydration and constipation
- Low potassium in the blood; muscle weakness, cramps and tiredness
- Loss of calcium in the urine and weak bones
- Calcium deposits in the kidneys
- Hearing loss (rare, in one type)
How is it diagnosed?
The levels of potassium, chloride and bicarbonate in the blood are checked. Salt and calcium are measured in the urine. A genetic test identifies the type. The type that begins before birth can be noticed by too much amniotic fluid during pregnancy.
Treatment and care
There is no treatment that cures the disease completely, but it can be controlled with lifelong treatment. Salt and potassium supplements are the main treatment. Medicines that reduce the loss in the kidneys are also used. Taking plenty of salt and water is recommended. For hearing loss, a cochlear implant can be done. Control usually becomes easier with age. The doctor who follows the disease decides which treatment is suitable.
For the family: inheritance and genetic counselling
It is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a carrier couple, the chance of an affected child in each pregnancy is 1 in 4. In marriages between relatives, this chance may be higher. Genetic counselling is recommended.
Source: MedlinePlus Genetics: Bartter syndrome · NORD: Bartter Syndrome
Key facts
- How common is it?
- New cases per year: 1-9 per 1 000 000 (Europe)
- How is it inherited?
- Autosomal dominant · Autosomal recessive · X-linked recessive
- When does it usually start?
- Adolescence, Adulthood, Before birth, Childhood, Infancy, Newborn period
- Reliable sources
- MedlinePlus (for families) · Orphanet
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
You are not alone: patient associations in Türkiye
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Support and help
- In an emergency in Türkiye, call 112.
- For psychological and social support, the ALO 183 Social Support Line (24/7, free from within Türkiye): alo183.aile.gov.tr
- For carers: Looking after yourself as a caregiver
- Preparing for a doctor visit · Collect your questions and symptom notes on one page, then print it and take it with you.
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
News about Bartter
Clinical trials (ClinicalTrials.gov)
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.
ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.
See all studies on ClinicalTrials.gov · Joining clinical trials
Kidney diseases: other news
TürkiyeDiagnosis and screening
Genetic testing in 63 adults with suspected inherited kidney disease in Ankara: Alport was the most common diagnosis
At Ankara University, 63 adults with kidney disease of unknown cause underwent genetic testing.
Peer-reviewed publicationAlport
TürkiyeResearch and clinical trials
Eye vessels and retina change in Alport syndrome: a 34-patient study from Ankara
Eye doctors at Başkent University studied the eyes of 34 patients with Alport syndrome.
Peer-reviewed publicationAlport
TürkiyeResearch and clinical trials
17 children with ARPKD in Istanbul: kidneys fail earlier in those with early symptoms
At Marmara University, 17 children diagnosed with ARPKD were studied.
Peer-reviewed publicationARPKD
Medical codes (for talking with your doctor and finding sources)
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:112 · ICD-11 GB90.43
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.